Angiotensin II receptor blocker/ja: Difference between revisions
Angiotensin II receptor blocker/ja
Created page with "==薬物動態の比較== {{Anchor|Pharmacokinetics comparison}}" Tags: Mobile edit Mobile web edit |
Created page with "{| class="wikitable" |+ 表1: ARB薬物動態の比較 |- ! 薬剤 ! 製品名 ! 半減期 [時間] ! ピーク血漿中濃度[Tmax] ! タンパク質結合率 [%] ! 生物学的利用能 [%] ! 腎/肝クリアランス [%] ! 食べ物の影響 ! 容量/日 [mg] ! 代謝/Transport protein/ja|トラ..." Tags: Mobile edit Mobile web edit |
||
Line 88: | Line 88: | ||
{{Anchor|Pharmacokinetics comparison}} | {{Anchor|Pharmacokinetics comparison}} | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ 表1: ARB[[pharmacokinetics/ja|薬物動態]]の比較 | ||
|- | |- | ||
! | ! 薬剤 | ||
! | ! 製品名 | ||
! [[Biological half-life]] [ | ! [[Biological half-life/ja|半減期]] [時間] | ||
! [[Cmax_(pharmacology)| | ! [[Cmax_(pharmacology)/ja|ピーク血漿中濃度[Tmax]]] | ||
! [[Protein binding]] [%] | ! [[Protein binding/ja|タンパク質結合率]] [%] | ||
! [[Bioavailability]] [%] | ! [[Bioavailability/ja|生物学的利用能]] [%] | ||
! | ! 腎/肝[[Clearance (medicine)/ja|クリアランス]] [%] | ||
! | ! 食べ物の影響 | ||
! | ! 容量/日 [mg] | ||
! [[Metabolism]]/[[Transport protein| | ! [[Metabolism/ja|代謝]]/[[Transport protein/ja|トランスポーター]] | ||
|- | |- | ||
| [[Losartan]] | | [[Losartan/ja|ロサルタン]] | ||
| Cozaar | | Cozaar | ||
| | | 2H | ||
| | | 1H | ||
| 98.7% | | 98.7% | ||
| 33% | | 33% | ||
| 10/90% | | 10/90% | ||
| | | ミネラル | ||
| 50–100 | | 50–100 | ||
| [[Sensitive substrates]]: [[CYP2C9]] | | [[Sensitive substrates/ja|センシティブ基質]]: [[CYP2C9/ja|CYP2C9]]と[[CYP3A4/ja|CYP3A4]] | ||
|- | |- | ||
| [[Losartan#Pharmacokinetics|EXP 3174]] | | [[Losartan/ja#Pharmacokinetics|EXP 3174]] ロサルタンの活性代謝物 | ||
| - | | - | ||
| | | 6–9H | ||
| | | ロサルタン経口投与3–4H後 | ||
| 99.8% | | 99.8% | ||
| – | | – | ||
Line 123: | Line 122: | ||
| – | | – | ||
| – | | – | ||
| | | AUCはフェニトインで63%、リファンピンで40%減少する;特定のCYP450アイソザイムは不明 | ||
|- | |- | ||
| [[Candesartan]] | | [[Candesartan/ja|カンデサルタン]] | ||
| Atacand | | Atacand | ||
| 9 | | 9 | ||
| | | 3–4H | ||
| >99% | | >99% | ||
| 15% | | 15% | ||
Line 134: | Line 133: | ||
| No | | No | ||
| 4–32 | | 4–32 | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> |